Viral safety testing of human cell lines used for biopharmaceutical manufacturing
In this series of presentations, experts from Takeda, Charles River, and PathoQuest discuss the current state of viral safety testing and the emergence of broad molecular methods, such as Next Generation Sequencing (NGS), that address some of the gaps in traditional viral safety testing of biologics.